Literature DB >> 31813005

Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.

Yinping Dong1, Yiran Qiu2, Jingyu Deng3, Wei Wang4, Zhe Sun5, Zhenning Wang5, Zhiwei Zhou6, Huimian Xu7, Han Liang8.   

Abstract

PURPOSE: The present study aims to validate possible stage migration of lymph node metastasis related to the insufficient examined lymph node (ELN) count in pN3a gastric cancer (GC) patients.
METHODS: 1976 pN3 patients who underwent the R0 surgery in three high-capacity institutions in China were enrolled to explore the stage migration of nodal involvement, and 3146 pN3 cases from the Surveillance, Epidemiology, and End Results (SEER) Program Registry were used as an external validation cohort.
RESULTS: After the propensity score matching of the Chinese cohort, the ELN count, as an independent predictor for GC outcome, was confirmed to be associated with the stage migration of lymph node metastasis in pN3a patients based on the univariate and multivariate survival analyses. Logistic regress was adopted to elucidate that the ELN count was an independent factor related to the long-term survival status of GC patients after curative surgery. Likelihood ratio test showed that the ELN count had the smallest Bayesian information criterion value among the clinicopathologic variables, corresponding to an efficient model to predict outcomes. Subsequently, stage migration of lymph node metastasis was predominantly detected in pN3a patient sub-group with insufficient (less than 16) ELN count, who presented with similar prognosis as the pN3b patients (P = 0.463) as per the stratum analysis with Kaplan-Meier. These methods were further validated using data from the SEER cohort, and the similar promising results were obtained.
CONCLUSION: pN3a patients with insufficient ELN count should be considered as pN3b cases to achieve accurate prognostic evaluation after curative gastrectomy.

Entities:  

Keywords:  Lymph node; Metastasis; Neoplasm; Prognosis; Stomach

Mesh:

Year:  2019        PMID: 31813005     DOI: 10.1007/s00432-019-03081-0

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  Increasing the Number of Examined Lymph Nodes is a Prerequisite for Improvement in the Accurate Evaluation of Overall Survival of Node-Negative Gastric Cancer Patients.

Authors:  Jingyu Deng; Hiroharu Yamashita; Yasuyuki Seto; Han Liang
Journal:  Ann Surg Oncol       Date:  2016-10-21       Impact factor: 5.344

2.  Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project.

Authors:  Takeshi Sano; Daniel G Coit; Hyung Ho Kim; Franco Roviello; Paulo Kassab; Christian Wittekind; Yuko Yamamoto; Yasuo Ohashi
Journal:  Gastric Cancer       Date:  2016-02-20       Impact factor: 7.370

3.  Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.

Authors:  Natalie G Coburn; Carol J Swallow; Alex Kiss; Calvin Law
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

4.  Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit.

Authors:  Yu-Yin Liu; Wen-Liang Fang; Frank Wang; Jun-Te Hsu; Chun-Yi Tsai; Keng-Hao Liu; Chun-Nan Yeh; Tse-Ching Chen; Ren-Chin Wu; Cheng-Tang Chiu; Ta-Sen Yeh
Journal:  Oncologist       Date:  2016-10-27

5.  Gastric cancer treatment guidelines in Japan.

Authors:  Toshifusa Nakajima
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

6.  Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset.

Authors:  Shogo Hayashi; Mitsuro Kanda; Seiji Ito; Yoshinari Mochizuki; Hitoshi Teramoto; Kiyoshi Ishigure; Toshifumi Murai; Takahiro Asada; Akiharu Ishiyama; Hidenobu Matsushita; Chie Tanaka; Daisuke Kobayashi; Michitaka Fujiwara; Kenta Murotani; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2018-11-27       Impact factor: 7.370

7.  Lymphadenectomy in gastric carcinoma. A prospective and prognostic study.

Authors:  J Jaehne; H J Meyer; H Maschek; H Geerlings; E Burns; R Pichlmayr
Journal:  Arch Surg       Date:  1992-03

8.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Authors:  A R Feinstein; D M Sosin; C K Wells
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

9.  Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database.

Authors:  Haejin In; I Solsky; B Palis; M Langdon-Embry; J Ajani; T Sano
Journal:  Ann Surg Oncol       Date:  2017-09-11       Impact factor: 5.344

10.  Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer.

Authors:  Xu-Guang Jiao; Jing-Yu Deng; Ru-Peng Zhang; Liang-Liang Wu; Li Wang; Hong-Gen Liu; Xi-Shan Hao; Han Liang
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

View more
  1 in total

1.  A Pilot Study of Prognostic Value of Metastatic Lymph Node Count and Size in Patients with Different Stages of Gastric Carcinoma.

Authors:  Yong Gao; Kun Wang; Xiao-Xian Tang; Jin-Liang Niu; Jun Wang
Journal:  Cancer Manag Res       Date:  2022-06-21       Impact factor: 3.602

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.